View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Aptar Pharma
22 March 2017

Aptar Pharma Congers Site Expansion Inaugurated March 20th

Aptar Pharma's new site expansion

Aptar Pharma Congers’ state-of-the-art manufacturing facility was inaugurated March 20th by AptarGroup’s president and chief executive officer (CEO) Stephan Tanda, president of Aptar Pharma Salim Haffar, and president of Aptar Pharma North America Alex Theodorakis. Several Aptar Pharma customers in North America were also invited.

Aptar Pharma’s newly-expanded facility’s capabilities will be used to complete premium injectable elastomeric component manufacturing, enabling the company to better serve its North American pharmaceutical customers.

President of the injectables division of Aptar Pharma Bas van Buijtenen said: "[The expansion] adds capacity to our network of global manufacturing sites and will be equipped with the latest technologies to meet growing quality requirements. The proximity to our North American customer base improves our service and responsiveness."

Following this event, Aptar Pharma will also welcome customers and partners during the Drug, Chemical, and Associated Technologies Association (DCAT) week and at Interphex in booth 1734.

Aptar Pharma is one of the leading suppliers of aerosol metering valves, a key sub-system of pressurised metered dose inhalers (pDMI) that enables accurate and...
Worth an estimated >2bn in 2009, the nasally administered systemic drugs market has an increasing generics sector, is placing greater emphasis on patient compliance and...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology